Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms. More
Supercritical fluid crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Enhancing the dissolution performance of small and large molecules in a range of dosage forms More
Improving the reconstitution and increasing the stability of biomolecules using supercritical fluid (SCF) processing More
Compositions and methods of use of A2 adenosine receptor (AR) agonists for treating conditions modulated by A2A and A2B ARs including myocardial ischemia, reperfusion injury, cystic fibrosis, erectile dysfunction, inflammation, restenosis and septic shock More
Cardiovascular physiology and atherosclerosis - prevention of cardiovascular complications in patients with renal failure or increased carbamylation. More
Initial results indicate that sodium nitrite can be used as a potential cost-effective platform therapy for a wide variety of disease indications characterized broadly by constricted blood flow or hypoxia. More
The first combined treatment for an effective and natural answer to the wide-spread problem of leg fatigue, heaviness, ankle swelling and related capillary breackdown. More
BiliSuit – a Fiber optic LED form fitting garment for treatment of infant hyperbilirubinemia (09-03)
Portable phototherapy device to treat jaundiced infants More
Contrast agents for ultrasonic imaging, destruction of clots, ultrasound-induced permeability of blood vessels and other tissues, targeted drug delivery, or to enhance ultrasonic tissue ablation. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Aug 2008 - 120 pages - $1,040
Jan 2009 - $15,200
Sep 2010 - 412 pages - $1,040
Nov 2010 - 7 pages - $500
Jan 2010 - $15,200
May 2011 - 43 pages - $500
Nov 2010 - 40 pages - $500
Aug 2008 - 352 pages - $2,615
Dec 2010 - 36 pages - $500
May 2011 - 23 pages - $125
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Therapeutic target
- Diabetic cardiovascular disease
- Hemorrhoidal
- Intermittent claudication
- Reperfusion injury
- Restenosis
- Shock
- Ulcer, pressure
- Ulcer, venous
- Varicose vein
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us